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Background:  Multiple needle attempts to gain a muscle twitch or a paresthesia for a classical supraclavicular 
brachial plexus block can increase the risks of nerve damage or pain.  The aims of this study were to obtain 
reliable clinical data on ultrasound-guided supraclavicular blocks, demonstrate the higher success rate and fewer 
complications, and design an injection method for patients whose brachial plexus can not be located.
Methods:  105 patients received an ultrasound-guided supraclavicular block. 40 ml of 1% mepivacaine was injected 
without a muscle twitch or paresthesia.  The groups were divided into two groups - Group A (n = 92, patients who 
had visible brachial plexus) and Group B (n = 13, patients whose brachial plexus can't be located).  After the blocks, 
the clinical characteristics such as the success rate, the time to onset, the extent of the sensory block, and occurrence 
of complications were evaluated.
Results:  The Success rate of Group A (98.9%) was higher than that of Group B (84.6%) (P < 0.05).  The overall success 
rate was 97.1%.  All patients could be operated on under sedation. The time to onset of Group A (12.6 ± 4.4 min) was 
shorter than that in Group B (23.1 ± 5.1 min) (P < 0.05).  The overall time to onset was 13.8 ± 5.5 min. There were no 
serious complications such as pneumothorax. 
Conclusions:  An ultrasound-guided supraclavicular block is very effective in even patients whose brachial plexus 
can not be located.  (Korean J Anesthesiol 2010; 58: 267-271)
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Introduction
    Supraclavicular brachial plexus block has many advantages. 
The brachial plexus is highly compact in the supraclavicular 
region. Therefore, a blockade achieves acute onset and excellent 
anesthesia of the entire arm and hand with a relatively small 
volume of local anesthetics. In addition, the arm doesn't need 
to be abducted as in an axillary brachial plexus block [1,2]. 
    The classical approaches for a supraclavicular block are all 
blind techniques that depend on sensory paresthesia or a nerve-
stimulated muscle contraction. Sometimes, multiple needle 
attempts are needed to elicit sensory paresthesia or a muscle 
twitch response, which can result in pain and complications 
such as neurological injury and pneumothorax [3,4]. 
    Ultrasound-guided brachial plexus block can increase the 
success rates and reduce the incidence of complications [5]. 
However it is very difficult to locate the structures such as 
subclavian artery and brachial plexus clusters in some people. 
    Therefore, the aims of this study were to obtain reliable 
clinical data on ultrasound-guidedsupraclavicular block, 
demonstrate the higher success rate and fewer complications, 
and design an injection method for the patients whose brachial 
plexus can not be located.
Materials and Methods
    After gaining protocol approval by our institutional review 
board, and informed consent from the patients, 105 patients 
with ASA grade 1 and 2 who were to undergo elective surgery of 
the forearm and hand were enrolled in this study (Table 1).
    No patients received premedication. Immediately after arriving 
in the operating room, standard monitoring equipments 
(EKG, non-invasive blood pressure measurement, pulse 
oximetry) were attached to all patients before performing the 
supraclavicular brachial plexus block.
    For the supraclavicular plexus block, the patients were placed 
in the supine position with their heads turned in the direction 
opposite the limbs to be anesthetized. The arms to be blocked 
were placed in an anatomical neutral position, along the body. 
Subsequently the probe (linear type, 12 MHz) of the ultrasound 
equipment (Vivid I
Ⓡ, GE Yokogawa Medical Systems Ltd., 
Tokyo, Japan) wrapped within a rubber glove was placed on 
the supraclavicular fossa to locate the subclavian artery and 
brachial plexus cluster. After local anesthetic infiltration, a 50 
mm 22 G insulated short beveled stimulation needle (Stimuplex
Ⓡ 
A, B. Braun Melsungen AG, Germany) was inserted toward the 
brachial plexus cluster from the lateral to medial in the long axis 
of the ultrasound beam after locating the subclavian artery and 
brachial plexus cluster.
    Once the needle tip reached the brachial plexus cluster on the 
ultrasound image, 1 to 2 ml of 1% mepivacaine was injected. If 
a local anesthetic was distributed around the brachial plexus 
cluster or the nerve was pushed to the periphery, the remaining 
local anesthetic (total 40 ml) was then injected (Fig. 1,  2).
Table 1. Demographic Characteristics of the Patients
 Group A  Group B
 Total of
 Group A and B
Sex (M/F)
Age (yr)
Height (cm)
Weight (kg)
 58/34
  40.4 ± 15.5
165.7 ± 8.8
63.3 ± 9.8
 8/5
  36.3 ± 15.2
165.0 ± 7.6
67.9 ± 9.2
 66/39
  39.9 ± 15.4
165.6 ± 8.6
63.9 ± 9.8
The values are reported as the mean ± standard deviation. Group 
A: patients with a visible brachial plexus, Group B: patients whose 
brachial plexus could not be located. 
Fig. 1. The ultrasound image of the supraclavicular brachial plexus 
at the level of the first rib. The subclavian artery and the trunks of the 
brachial plexus can be seen. SA: subclavian artery, BP: brachial plexus.
Fig. 2. The ultrasound image of the supraclavicular brachial plexus 
after the local anesthetic injection at the level of the first rib. SA: 
subclavian artery, LA: local anesthetic distribution.269 www.ekja.org
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    The needle tip was repositioned if the local anesthetic 
spreaded inappropriately. Sometimes the patients complained 
of paresthesia. When this occurred, the needle was withdrawn 
and repositioned until the patients did not complain it. During 
the study, some cases with a brachial plexus that was vague or 
not visible on the ultrasound image were found (Fig. 3). Thus 
the patients were divided into two groups according to the 
visibility of the brachial plexus cluster on the ultrasound image. 
Group A consisted of patients in whom the brachial plexus 
cluster could be visualized on the ultrasound image while the 
Group B consisted of patients in whom the brachial plexus 
cluster was vague or not visualized on the ultrasound image. 
    In the case of Group B, the local anesthetic was injected at the 
distance of its diameter (25 ml) from the subclavian artery and 
superior lateral (15 ml) to the subclavian artery according to the 
normal anatomy (Fig. 3).
    From 1 minute to 30 minutes after the blocks, the other anes-
thesiologist tested the extent of the sensory block at 1 minute 
intervals. The onset of the sensory block was evaluated using 
a pinprick test with a 26 G needle. The following five nerves 
were tested: 1) musculocutaneous nerve (lateral side of the 
forearm); 2) radial nerve (dorsum of the hand over the 2nd 
metacarpophalangeal joint); 3) median nerve (medial thenar 
eminence); 4) ulnar nerve (little finger); 5) median cutaneous 
nerve (medial side of the forearm). A successful block was 
defined as complete sensory block of the above 5 terminal 
nerves assessed within 30 minutes of the local anesthetic 
injection and operability. 
    All patients were checked for Horner's syndrome, voice changes, 
and dyspnea or chest discomfort, and they were sedated with 
midazolam or propofol after the tests. Postoperative chest 
X-rays were then obtained to check for hemi-diaphragmatic 
paralysis and pneumothorax . 
    The data was analyzed using a Student t-test, Mann-Whitney 
U test and Chi-square test. A P value < 0.05 was considered 
significant.
Results
    The overall success rate of the block was 97.1% (102/105 
patients). The success rate in Group A (98.9%, 91/92 patients) 
was higher than that in Group B (84.6%, 11/13 patients) (P < 
0.05). However 3 failures could be operated on under sedation 
with the iv midazolam and propofol infusion.
    The overall time to onset was 13.8 ± 5.5 min. The time to onset 
in Group B (23.1 ± 5.1 min) was longer than that in Group A (12.6 
± 4.4 min) (P < 0.05) (Table 2).
    Dyspnea or chest discomfort was encountered in 8.7% and 
15.4% of Group A and B respectively, but differences were not 
significant. Hemidiaphragmatic paralysis was encountered 
in 36.6% and 30.8% of Group A and B, respectively, but the 
differences were not significant. A recurrent laryngeal nerve 
block was observed in 2.2% of Group A. But the differences 
were not significant. There were no differences in the other side 
effects (Table 3).
Fig. 3. Ultrasound image of the supraclavicular brachial plexus at the 
level of the first rib. The wall of subclavian artery is vague and the 
brachial plexus can not be seen well. SA: subclavian artery, Point 1: 
the first injection site, Point 2: the second injection site.
Table 3. Incidence of Side Effects during Block 
 
 Group A
 (%) 
 Group B
 (%) 
 Total of 
Group A and B (%)
Horner's syndrome
Dyspnea or chest
  discomfort
Recurrent laryngeal
  nerve block
Hemidiaphragmatic
  paralysis
Pneumothorax 
 68.5
8.7
2.2
32.6
0
69.2
15.4
0
30.8
0
 68.6 
9.5 
1.9
 32.4 
 0 
The values are reported as the mean ± standard deviation. Group A: 
patients with a visible brachial plexus, Group B: patients whose bra-
chial plexus could not be located. 
Table 2. Time to Onset of Each 5 Terminal Nerve
Sensory distribution
 Time to onset (minutes)
 Group A   Group B 
 Average of
 Group A and B
Musculocutaneous nerve
Radial nerve
Ulna nerve
Median nerve
Median cutaneous nerve
Average of all nerves
 8.0 ± 2.8 
 7.4 ± 3.1 
 11.0 ± 5.2
 9.0 ± 4.1
 8.3 ± 4.3
 12.6 ± 4.4
 10.6 ± 3.0*
 11.6 ± 7.2
 22.0 ± 5.6*
 14.4 ± 4.5* 
 15.4 ± 6.5*
 23.1 ± 5.1*
 8.3 ± 2.9
 7.8 ± 3.9
 12.2 ± 6.2
 9.5 ± 4.5
 9.1 ± 5.1
 13.8 ± 5.5
The values are reported as the mean ± standard deviation. Group 
A: patients with a visible brachial plexus, Group B: patients whose 
brachial plexus could not be located. *P < 0.05 compared with Group A.270 www.ekja.org
Ultrasound-guided supraclavicular block Vol. 58, No. 3, March 2010
Discussion
    The reported success rates in ultrasound-guided supraclavicular 
block varies between 78% and 95% [6-8]. However our overall 
success rate was 97.1% (102/105 patients), which is comparable 
to other studies using a combination of ultrasound and nerve 
stimulation techniques.
    The reason why our success rate was higher is that this 
study used a larger local anesthetic volume (40 ml), multiple 
injections and a single well-trained operator performed the 
blocks, whereas the other studies used a lower local anesthetic 
volume down to 20 ml and many operators including residents. 
    Sensory paresthesia or motor response is believed to be a 
definitive sign that the needle is touching the nerve directly. 
However after the introduction of ultrasound, an operator can 
see the precise needle location without eliciting paresthesia or a 
motor response. 
    Therefore, it is believed that a paresthesia or motor response 
is not the gold standard for a correct needle location for a 
supraclavicular brahcial plexus block. This concept is not 
new. Beach et al. [9] demonstrated that the use of a nerve 
stimulator did not improve the efficacy of ultrasound-guided 
supraclavicular blocks, which was also observed in this study. 
This suggests that a paresthesia or a motor response is not the 
gold standard for a successful block.
    13 cases (12.4%) with brachial plexus that was vague or not 
visible on the ultrasound image were encountered during the 
study. In these cases, local anesthetics were injected according 
to the normal anatomy. It was assumed that local anesthetics 
injected lateral or superior lateral to the subclavian artery could 
reach the brachial plexus because the location of the brachial 
plexus was normally located lateral or superior lateral to the 
subclavian artery. The success rate in Group B was 84.6% (11/13 
patients), which was lower than that in Group A (98.9%, 91/92 
patients), the onset of the block was also slower than that of 
the patients whose brachial plexus was visible. This means 
that the local anesthetics injected took more time to reach the 
brachial plexus in those patients whose brachial plexus could 
not be located. However Chin et al. [10] reported a case of an 
anomalous brachial plexus anatomy. The patient's superior 
trunk of the brachial plexus was medial to the subclavian artery 
at the level of the first rib. In the light of their report, the method 
performed in the present study might have the problem in the 
patients with anomalous brachial plexus. It is believed that a 
reduced block can occur in the patients with an anomalous 
brachial plexus if the local anesthetics are injected by this 
method. However the 2 failures in Group B could be operated 
on under sedation. 
    A nerve stimulator was not used in this study. It is believed that 
the success rate could be higher in even patients whose brachial 
plexus can not be located if a nerve stimulator had been used 
during the ultrasound-guided supraclavicular block in Group B. 
    Athough a supraclavicular block has many advantages, it can 
have important or fatal complications, which include dyspnea 
and pneumothorax [1,2]. Dyspnea occurs from diaphragmatic 
paralysis or pneumothorax. However the dyspnea caused 
by hemidiaphragmatic paralysis is not clinically important 
in patients without respiratory diseases such as chronic 
obstructive disease or asthma. However dyspnea with 
pneumothorax can be fatal.
    There is a 100% incidence of hemidiaphragmatic paralysis 
accompanied with a 25% decrease in the forced vital capacity 
(FVC) when an interscalene block is performed [11]. However, 
there is only a 30 to 50% incidence of hemidiaphragmatic 
paralysis with no decrease in the FVC when a supraclavicular 
block is performed [12,13]. Therefore dyspnea caused by 
diaphragmatic paralysis in supraclavicular block is not clinically 
important.
    In this study, 9.5% of patients complained of dyspnea or chest 
discomfort and 32.4% patients showed hemidiaphragmatic 
paralysis on the post operative chest X-rays. This is similar to the 
incidence of hemidiaphragmatic paralysis reported by Farrar 
et al. [12]. Their study included both a quantitative pulmonary 
function test and chest X-ray. However, quantitative pulmonary 
function test with spirometer was not performed in this study. 
Therefore the dyspnea or chest discomfort that the patients 
complained of could not be tested objectively. 
    The dyspnea caused by pneumothorax can be fatal after a 
supraclavicular block. Therefore some anesthesiologists avoid a 
supraclavicular block for fear of pneumothorax. The published 
incidence of pneumothorax varies from 0.5% to 6% in the 
classical supraclavicular approach with paresthesia for nerve 
localization [1,2]. Ultrasound guidance is believed to decrease 
the incidence of pneumothrax during a supraclavicular brachial 
plexus block [5]. Indeed no pneumothorax has been reported 
until now. Unlike conventional techniques, ultrasound can 
show the size, depth, and precise location of the brachial 
plexus and its adjacent structures including the first rib, pleura 
and movement of the needle. Therefore, real time ultrasound 
imaging can help avoid pneumothorax.
    In conclusions, a supraclavicular block using ultrasound is a 
useful method for regional anesthesia. An almost 100% block 
can be obtained without eliciting sensory paresthesia or a motor 
response. It can also help avoid pneumothorax, which is an 
important complication of a supraclavicular block. This study 
also showed a successful block without gaining a precise image 
of brachial plexus. It is expected that the use of supraclavicular 
brachial plexus block will become more widespread in the 
future.271 www.ekja.org
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